MIMEDX GROUP, INC. MDXG
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus
Chart by TradingView
5/9
Piotroski F — financial health
8.06
Altman Z″ — distress risk · safe
—
Dividend payout · no dividend
Financials (annual, from 10-K)
| FY | Revenue | Net income | Gross profit | Free cash flow | Equity |
|---|---|---|---|---|---|
| 2025 | $418.6M | $48.6M | $345.6M | — | $256.5M |
| 2024 | $348.9M | $42.4M | $288.8M | — | $193.1M |
| 2023 | $321.5M | $58.2M | $266.8M | $24.8M | $142.7M |
| 2022 | $267.8M | -$30.2M | $219.5M | -$19.4M | -$18.0M |
| 2021 | $242.0M | -$10.3M | $202.4M | -$13.1M | $82,000 |
| 2020 | $248.2M | -$49.3M | $208.9M | — | -$150,000 |
Recent insider activity (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| Maersk-Moller Kimberly | Chief Commercial Officer | 2026-06-24 | Tax withheld | 19,820 | $3.83 |
| BIERMAN JAMES L | director | 2026-06-10 | Grant | 50,913 | $3.64 |
| PUHY DOROTHY E | director | 2026-06-10 | Grant | 50,913 | $3.64 |
| Newton Todd | director | 2026-06-10 | Grant | 50,913 | $3.64 |
| HAWKINS WILLIAM A | director | 2026-06-10 | Grant | 50,913 | $3.64 |
| Olson Tiffany | director | 2026-06-10 | Grant | 50,913 | $3.64 |
| Hulse William Frank IV | General Counsel and CAO | 2026-03-13 | Tax withheld | 20,245 | $4.38 |
| Maersk-Moller Kimberly | Chief Commercial Officer | 2026-03-13 | Tax withheld | 6,762 | $4.38 |
Why these scores methodology →
Piotroski F-score: 5/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 8.06 (safe)
- Working capital / assets 0.622
- Retained earnings / assets -0.125
- EBIT / assets 0.186
- Equity / liabilities 2.979
Source: SEC EDGAR filings · CIK 0001376339 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.